DKD Approval for Rare Disease

DKD obtained approval as Food for Special Medical Purposes for Osteogenesis Imperfecta, Ehlers-Danlos Syndrome, Deficiency Rickets

17 March 2022

DKD (ORAL SOLUBLE FILM FOR VITAMIN D SUPPLEMENTATION) recently obtained the approval as Food for Special Medical Purposes also for pathologies related to Hypovitaminosis D: Osteogenesis Imperfecta, Ehlers-Danlos Syndrome and Deficiency Rickets.

Dkd is a Food for Special Medical Purposes and this status is useful to get the reimbursement of the product. It also simplifies the process of obtaining this high-dose Vitamin D, characterized by an easy-to-take pharmaceutical form that can improve compliance.

 

https://www.neupharma.it/hypovitaminosis

https://www.neupharma.it/prodotti/alimenti-fibrosi-cistica/dkd-neupharma


Share on: